Cleared Special

Cefaly

K160237 · Cefaly Technology · Neurology
Mar 2016
Decision
32d
Days
Class 2
Risk

About This 510(k) Submission

K160237 is an FDA 510(k) clearance for the Cefaly, a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II — Special Controls, product code PCC), submitted by Cefaly Technology (Herstal, BE). The FDA issued a Cleared decision on March 4, 2016, 32 days after receiving the submission on February 1, 2016. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5891.

Submission Details

510(k) Number K160237 FDA.gov
FDA Decision Cleared SESE
Date Received February 01, 2016
Decision Date March 04, 2016
Days to Decision 32 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PCC — Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.

Similar Devices — PCC Stimulator, Nerve, Electrical, Transcutaneous, For Migraine

All 16
ELEXIR 2.0 (ALLIVE3)
K242719 · Nu Eyne Co., Ltd. · Nov 2024
CEFALY Connected - OTC, CEFALY Connected - Rx
K234029 · Cefaly Technology · Jul 2024
DOOPANG
K232749 · Ybrain, Inc. · Jun 2024
Milieve (YPS-301BD)
K233751 · Soterix Medical, Inc. · Jun 2024
TENS device-HeadaTerm 2 (Model: YF-HT2)
K230782 · Wat Medical Technology, Inc. · Feb 2024
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx
K212071 · Cefaly Technology · Dec 2022